Bentham Science Logo

Track Your Manuscript:

Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access


Current Drug Targets, Volume 16 - Number 12

Identification of Lipid Species Linked to the Progression of Non-alcoholic Fatty Liver Disease

, 16(12): 1293 - 1300

Yuki Kawano, Shin Nishiumi, Masaya Saito, Yoshihiko Yano, Takeshi Azuma and Masaru Yoshida

DOI: 10.2174/1389450116666150408103318

Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease

, 16(12): 1301 - 1314

Wensheng Liu, Susan S Baker, Robert D Baker and Lixin Zhu

DOI: 10.2174/1389450116666150427155342

IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression

, 16(12): 1315 - 1323

Daniel A Giles, Maria E Moreno-Fernandez and Senad Divanovic

DOI: 10.2174/1389450116666150531153627

Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?

, 16(12): 1332 - 1346

Michele T. Pritchard and Jennifer M. McCracken

DOI: 10.2174/1389450116666150825111439

ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy

, 16(12): 1356 - 1371

Haigang Cui, Anna J. Zhang, Mingwei Chen and Johnson J. Liu

DOI: 10.2174/1389450116666150330113506


Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.



Related Journals

Related eBooks

eBooks Catalog